CalciMedica, Inc.
Price Action
Technical Summary
CONSOLIDATINGCalciMedica, Inc. is in a consolidation phase, trading with mixed signals as moving averages converge. Relative strength is weak (RS Rating: 33), showing significant lag compared to the market leaders. Earnings growth of 183% provides fundamental context to the price action. However, price is extended 37% above the 50-day line, increasing the risk of a mean reversion.
Trend Template (Minervini)
Price vs Moving Averages
| Period | Value | Spread | Signal |
|---|---|---|---|
| 20 SMA | $0.84 | +16.83% | ABOVE |
| 50 SMA | $0.72 | +36.55% | ABOVE |
| 100 SMA | $0.68 | +44.93% | ABOVE |
| 150 SMA | $2.03 | -51.30% | BELOW |
| 200 SMA | $2.30 | -57.12% | BELOW |
Price Performance
Technical Indicators
Risk Profile
Volume Analysis
Earnings Momentum
Growth Trends
Compounded Sales Growth
Compounded Profit Growth
Stock Price CAGR
Return on Equity
Key Metrics
Frequently Asked Questions
Is CALC in an uptrend right now?
CALC has a trend score of 2/4 based on Minervini's Stage Analysis. Currently showing partial alignment - 2 of 4 trend criteria are met.
Is CALC overbought or oversold?
CALC's RSI (14) is 51. The stock is in neutral territory, neither overbought nor oversold.
Is CALC outperforming the market?
CALC has a Relative Strength (RS) Rating of 33 out of 99. CALC is currently lagging the broader market.
Where is CALC in its 52-week range?
CALC is trading at $0.99, which is 14% of its 52-week high ($7.20) and 8% above its 52-week low ($0.46).
How volatile is CALC?
CALC has a Beta of -0.11 and 52-week volatility of 142%. It's less volatile than the S&P 500 - generally more stable.